Their data suggest that the ADRB3 gene may trigger dyslipidemia by regulating the expression of proprotein convertase subtilisin/kexin type 9 (PCSK9) gene and LDL receptor (LDLR) gene. The gene discussed is LDLR; the disease is metabolic syndrome.